Gentian Diagnostics ASA (OSL:GENT)

Gentian Diagnostics ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	910	605	640	632	1,110	840
Market Cap Growth	51.28%	-5.54%	1.22%	-43.06%	32.20%	-12.61%
Enterprise Value	825	517	574	555	1,000	691
Last Close Price	59.00	38.88	41.17	40.67	71.42	54.06
PE Ratio	21.45	13.35	-	-	-	-
Forward PE	57.28	28.52	-	-	-	-
PS Ratio	5.27	3.98	4.74	5.65	11.10	10.65
PB Ratio	4.50	3.12	4.37	4.10	6.35	4.32
P/TBV Ratio	5.36	3.65	5.10	4.97	7.42	4.32
P/FCF Ratio	77.56	50.05	44.13	-	-	-
P/OCF Ratio	73.38	44.93	41.40	-	-	-
EV/Sales Ratio	4.78	3.40	4.24	4.96	10.00	8.75
EV/EBITDA Ratio	27.55	27.82	-	-	-	-
EV/EBIT Ratio	35.58	32.91	-	-	-	-
EV/FCF Ratio	70.34	42.83	39.55	-	-	-
Debt / Equity Ratio	0.01	0.05	0.09	0.10	0.11	0.11
Debt / EBITDA Ratio	0.06	0.45	-	-	-	-
Debt / FCF Ratio	0.16	0.83	0.90	-	-	-
Asset Turnover	0.82	0.74	0.73	0.56	0.45	0.34
Inventory Turnover	1.63	1.67	1.87	1.54	1.71	1.67
Quick Ratio	4.16	3.85	4.13	4.58	6.10	7.67
Current Ratio	5.98	5.38	5.60	6.33	7.42	8.59
Return on Equity (ROE)	23.54%	26.59%	-7.08%	-14.36%	-13.43%	-8.67%
Return on Assets (ROA)	6.87%	4.78%	-4.32%	-7.27%	-6.39%	-4.82%
Return on Capital (ROIC)	7.79%	5.40%	-4.85%	-8.00%	-6.96%	-5.19%
Return on Capital Employed (ROCE)	11.40%	7.90%	-8.20%	-14.00%	-12.10%	-8.40%
Earnings Yield	4.70%	7.49%	-1.66%	-3.74%	-2.23%	-2.08%
FCF Yield	1.29%	2.00%	2.27%	-3.57%	-2.53%	-1.81%
Dividend Yield	0.70%	1.03%	-	-	-	-
Buyback Yield / Dilution	1.29%	-2.21%	-	-0.04%	-0.07%	-0.01%
Total Shareholder Return	1.98%	-1.18%	-	-0.04%	-0.07%	-0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.